Skip to main content

Table 6 Absolute frequency of missing daily AH, MP values, and daily UF-DBD scores per patient

From: Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

Patient group

Number of patients

Average number of days in period

Mean

SD

Median

IQR (Q1-Q3)

Min-Max

Screening period

Patients with AH measurements

  Daily AH values

241

28

3.1

3.7

2.0

0.0–5.0

0.0–21.0

  Daily MP values

241

28

2.8

3.6

1.0

0.0–4.0

0.0–19.0

  Daily UF-DBD scores

241

28

2.8

3.5

1.0

0.0–4.0

0.0–21.0

US Patients with AH measurements

  Daily AH values

92

28

4.6

4.3

3.5

1.0–6.5

0.0–21.0

  Daily MP values

92

28

4.1

4.2

3.0

1.0–6.0

0.0–19.0

  Daily UF-DBD scores

92

28

4.3

4.2

3.5

1.0–6.0

0.0–21.0

28 days prior to and including EOT

Patients with AH measurements

  Daily AH values

223

28

3.2

4.1

2.0

0.0–4.0

0.0–21.0

  Daily MP values

223

28

3.0

4.0

2.0

0.0–4.0

0.0–21.0

  Daily UF-DBD scores

223

28

2.9

3.8

2.0

0.0–4.0

0.0–21.0

US Patients with AH measurements

  Daily AH values

82

28

5.0

4.9

4.0

2.0–7.0

0.0–21.0

  Daily MP values

82

28

4.8

4.7

4.0

1.0–7.0

0.0–21.0

  Daily UF-DBD scores

82

28

4.6

4.4

4.0

1.0–6.0

0.0–21.0

  1. The patient group analyzed here refers to those who had AH measurements from any study center. Patients from Japan were excluded as they were not asked to collect sanitary items for the AH method
  2. AH Alkaline hematin method, EOT End of treatment, IQR Interquartile range, Max Maximum, Min Minimum, MP (MP SAP-c v3) Menstrual pictogram superabsorbent polymer-containing version 3, N Number of patients, UF-DBD Uterine Fibroid Daily Bleeding Diary